Review and re-appraisal of patients treated with splenectomy for immune thrombocytopenic purpura at five years and beyond
Includes bibliographical references. === The risk of pneumococcal infection post splenectomy is life long so all patients undergoing splenectomy are given polyvalent (23-valent) unconjugated pneumococcal polysaccharide vaccine, preoperatively. The aim of this study was 1. to measure the success of s...
Main Author: | |
---|---|
Other Authors: | |
Format: | Dissertation |
Language: | English |
Published: |
University of Cape Town
2014
|
Subjects: | |
Online Access: | http://hdl.handle.net/11427/2833 |
id |
ndltd-netd.ac.za-oai-union.ndltd.org-uct-oai-localhost-11427-2833 |
---|---|
record_format |
oai_dc |
spelling |
ndltd-netd.ac.za-oai-union.ndltd.org-uct-oai-localhost-11427-28332020-10-06T05:10:59Z Review and re-appraisal of patients treated with splenectomy for immune thrombocytopenic purpura at five years and beyond Seth, Yunus S Novitzky, Nicholas Haematology Includes bibliographical references. The risk of pneumococcal infection post splenectomy is life long so all patients undergoing splenectomy are given polyvalent (23-valent) unconjugated pneumococcal polysaccharide vaccine, preoperatively. The aim of this study was 1. to measure the success of splenectomy at a tertiary institution at 5 years and beyond. 2. To review the incidence of complications peri-operatively and long term. 3. Review the need for possible re-vaccination (as recommended in American and British guidelines and 4. perform a re-appraisal of patients found to be refractory to treatment. 2014-07-28T13:32:44Z 2014-07-28T13:32:44Z 2002 Master Thesis Masters MMed http://hdl.handle.net/11427/2833 eng application/pdf University of Cape Town Faculty of Health Sciences Division of Clinical Haematology |
collection |
NDLTD |
language |
English |
format |
Dissertation |
sources |
NDLTD |
topic |
Haematology |
spellingShingle |
Haematology Seth, Yunus S Review and re-appraisal of patients treated with splenectomy for immune thrombocytopenic purpura at five years and beyond |
description |
Includes bibliographical references. === The risk of pneumococcal infection post splenectomy is life long so all patients undergoing splenectomy are given polyvalent (23-valent) unconjugated pneumococcal polysaccharide vaccine, preoperatively. The aim of this study was 1. to measure the success of splenectomy at a tertiary institution at 5 years and beyond. 2. To review the incidence of complications peri-operatively and long term. 3. Review the need for possible re-vaccination (as recommended in American and British guidelines and 4. perform a re-appraisal of patients found to be refractory to treatment. |
author2 |
Novitzky, Nicholas |
author_facet |
Novitzky, Nicholas Seth, Yunus S |
author |
Seth, Yunus S |
author_sort |
Seth, Yunus S |
title |
Review and re-appraisal of patients treated with splenectomy for immune thrombocytopenic purpura at five years and beyond |
title_short |
Review and re-appraisal of patients treated with splenectomy for immune thrombocytopenic purpura at five years and beyond |
title_full |
Review and re-appraisal of patients treated with splenectomy for immune thrombocytopenic purpura at five years and beyond |
title_fullStr |
Review and re-appraisal of patients treated with splenectomy for immune thrombocytopenic purpura at five years and beyond |
title_full_unstemmed |
Review and re-appraisal of patients treated with splenectomy for immune thrombocytopenic purpura at five years and beyond |
title_sort |
review and re-appraisal of patients treated with splenectomy for immune thrombocytopenic purpura at five years and beyond |
publisher |
University of Cape Town |
publishDate |
2014 |
url |
http://hdl.handle.net/11427/2833 |
work_keys_str_mv |
AT sethyunuss reviewandreappraisalofpatientstreatedwithsplenectomyforimmunethrombocytopenicpurpuraatfiveyearsandbeyond |
_version_ |
1719347863802085376 |